Organon Long Term Debt 2019-2025 | OGN
Organon long term debt from 2019 to 2025. Long term debt can be defined as the sum of all long term debt fields.
| Organon Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $8,860 |
| 2023 | $8,751 |
| 2022 | $8,905 |
| 2021 | $9,125 |
| 2020 | $0 |
| 2019 | $70 |
| 2018 | $0 |
| Organon Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-03-31 | $8,936 |
| 2024-12-31 | $8,860 |
| 2024-09-30 | $8,739 |
| 2024-06-30 | $8,647 |
| 2024-03-31 | $8,705 |
| 2023-12-31 | $8,751 |
| 2023-09-30 | $8,646 |
| 2023-06-30 | $8,722 |
| 2023-03-31 | $8,703 |
| 2022-12-31 | $8,905 |
| 2022-09-30 | $8,691 |
| 2022-06-30 | $8,884 |
| 2022-03-31 | $9,085 |
| 2021-12-31 | $9,125 |
| 2021-09-30 | $9,259 |
| 2021-06-30 | $9,309 |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $70 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.594B | $6.403B |
| Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.179B | 27.04 |
| CVS Health (CVS) | United States | $86.198B | 10.71 |
| Elevance Health (ELV) | United States | $84.314B | 10.88 |
| Cencora (COR) | United States | $57.484B | 20.00 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.963B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.509B | 17.45 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.205B | 0.00 |
| Solventum (SOLV) | United States | $12.912B | 13.67 |
| CochLear (CHEOY) | Australia | $12.870B | 0.00 |
| ICON (ICLR) | Ireland | $11.851B | 11.02 |
| Revvity (RVTY) | United States | $11.644B | 20.04 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Avantor (AVTR) | United States | $9.363B | 13.60 |
| HealthEquity (HQY) | United States | $9.068B | 39.72 |
| Medpace Holdings (MEDP) | United States | $8.818B | 23.42 |
| Sonic Healthcare (SKHHY) | Australia | $8.465B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.445B | 14.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.269B | 25.15 |
| BrightSpring Health Services (BTSG) | United States | $4.058B | 37.23 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.781B | 36.17 |
| Alignment Healthcare (ALHC) | United States | $2.722B | 0.00 |
| Concentras Parent (CON) | United States | $2.652B | 15.33 |
| GeneDx Holdings (WGS) | United States | $2.556B | 98.45 |
| PACS (PACS) | United States | $1.958B | 0.00 |
| Ardent Health (ARDT) | United States | $1.904B | 8.12 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.796B | 13.63 |
| GoodRx Holdings (GDRX) | United States | $1.761B | 35.21 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.181B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| CareDx (CDNA) | United States | $1.074B | 16.77 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| LifeMD (LFMD) | United States | $0.615B | 0.00 |
| Embecta (EMBC) | United States | $0.542B | 3.65 |
| InnovAge Holding (INNV) | United States | $0.532B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| SBC Medicals (SBC) | United States | $0.464B | 0.00 |
| Omada Health (OMDA) | $0.460B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.312B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.249B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| So-Young (SY) | China | $0.209B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.096B | 0.00 |
| KindlyMD (NAKA) | United States | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.051B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |